Proteomics is a systems physiology discipline to address the large-scale characterization of protein species within a biological system, be it a cell, a tissue, a body biofluid, an organism, or a cohort population. Building on advances from chemical analytical platforms (e.g., mass spectrometry and other technologies), proteomics approaches have contributed powerful applications in cardiovascular biomedicine, most notably in: 1) the discovery of circulating protein biomarkers of heart diseases from plasma samples; and 2) the identification of disease mechanisms and potential therapeutic targets in cardiovascular tissues, in both preclinical models and translational studies. Contemporary 
First, it has gradually emerged from large-scale studies that transcript and protein changes in a system may, at times, correspond poorly-with transcript levels explaining as little as 10% to 30% of variations in protein abundance. Although the exact contribution of transcripts to protein-level abundance is debated, it is evident that in the heart and other organs, a large number of post-transcriptional modulators can alter disease-driver protein expression and function during pathogenesis, without changes in transcript abundance (9, 10) . These modulators include components of the nonsensemediated decay pathway, long noncoding RNAs, and microRNAs (11) (12) (13) (14) .
Second, plasma proteins provide an accessible readout of the status of potentially all tissues, and are the sources of many current biomarkers in use ( Table 1) . Clinically useful biomarkers can include circulating proteins that have been secreted or leaked directly into the plasma from resident cells (e.g., myocytes) following diseases or injuries (15) Proteomics technologies allow researchers to measure protein function on a large scale, and hence interrogate the molecular layer that closely abuts physiological phenotypes (16) . However, the complexity of the human proteome also presents a daunting analytical challenge for large-scale characterization. For example, circulating proteins in human plasma, found at a concentration of w70 mg/ml, are estimated to comprise at least 10,000 distinct protein species (17) over a concentration range of >10 orders of magnitude (10-billionfold differences) (18) In the following 3 segments of this review, we will discuss 3 aspects of proteomics applications in cardiovascular biomedical research: 1) study design for biomarker research and discovery, with discussions on approaches to circumvent analytical challenges; 2) characterization of multidimensional protein parameters in disease mechanism research; and 3) interpretation and validation of proteomics data or methodologies. overview of data acquisition and analysis; see Table 2 for a glossary of selected technological terms commonly in use.
GLOBAL DISCOVERY PROTEOMICS. Global discovery approaches offer an unbiased view of the protein species that may be found in a sample. Shotgun proteomics is 1 of the most widely used and standardized global discovery strategies. In shotgun analysis, proteins are first enzymatically digested (e.g., using trypsin) into peptides in vitro, and then subjected to tandem mass spectrometry (MS) analysis. The resulting mass spectra are then searched against a protein sequence database (19) or spectral library This figure lists major components in common proteomics workflows, as well as their associated experimental considerations in biomarker discovery and disease studies. From top to bottom, protein samples are collected from the plasma of human cohorts or cardiac tissues in animal models according to study goals (either biomarker discovery or mechanistic studies). Three major study approaches (discovery, targeted, and targeted discovery) take different strategies between proteome coverage and analytical throughput, and use different technological platforms, including mass spectrometry and protein arrays. Following the acquisition of largescale datasets, data are processed to identify the protein species present and to deduce their relative quantities across samples. Subsequently, a number of statistical and bioinformatics workflows are used in data interpretation to extract insights from datasets. Network analysis casts proteins in the context of interaction networks or altered cellular pathways. Statistical learning and modeling methods connect the identified molecular features to orthogonal phenotypes, identify signatures, and offer information on subject classification or predictive analysis. The identified protein signatures will require validation, which can be achieved by complementary translational studies, including in vitro biochemical analysis and large cohorts. PTM ¼ post-translational modifications.
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JACC VOL. 68, NO. 25, 2016 Proteomics in Cardiovascular Research and flexibility, but, on the upside, panels of "likely bets" can be preselected by manufacturers or by the investigators to increase the probability of discovery (31). A number of MS-based (e.g., sequential window acquisition of all theoretical mass spectra) (32) and Amino acid sequence A segment of the primary structure of the protein where individual amino acids are linked by peptide bonds.
Aptamer array A non-MS proteomics technology where single-stranded DNA oligonucleotides with affinity for specific protein targets are used as a means to detect and quantify up to w1,000 different protein targets.
Liquid chromatography A common front-end separation technology in proteomics experiments to fractionate complex sample mixture. It is used to resolve and enrich peptides by their chemical properties such as size, hydrophobicity, or charge, and the like.
MS
An analytical technology to measure the mass of an analyte (e.g., peptide, protein, amino acid, and so on) in the format of mass-to-charge ratio.
Mass spectrum The data output of MS. A mass spectrum is a plot displaying the relative intensity or abundance of the analyte ions (y-axis) and their mass-to-charge ratio (x-axis).
Mass/charge (m/z) The principal measurement of a mass spectrometer: the mass of the ionized analytes divided by the charge they carry. Also commonly referred to as mass-to-charge ratio.
Multiple-reaction monitoring A targeted proteomics approach in which a particular type of mass spectrometer is programmed to only measure a few peptides and their fragment ions of a target protein of interest, while filtering out all other peptides and proteins in the sample, thus enhancing specificity and sensitivity of the detection/quantification of the targets. Also known as SRM.
Search engine A software tool used in sequence database search to identify proteins from MS data (e.g., SEQUEST) (110).
Sequence database search
A method to identify proteins from MS data by matching the collected experimental mass spectra to theoretical mass spectra generated from a protein sequence database, such as UniProt (19) or RefSeq (111).
Spectral library search A method to identify peptides by matching MS data to previously known experimental spectra in a library, such as COPaKB (21) or PeptideAtlas (20).
Shotgun proteomics A method to identify and quantify proteins on a large scale, in which proteins are first digested into short segments (peptides) that are amenable to sequence determination via tandem MS analysis. The identity of each present protein is then inferred from the sequenced peptides. Also known as bottom-up proteomics.
Tandem mass spectrometry
An analytical method involving the fragmentation of peptides (or other analytes) via multiple stages of MS analyses to obtain sequence/structural information of the analytes. Also known as MS/MS or MS 2 .
TMT/iTRAQ Commercially available chemical labels containing stable isotopes, which can be used to label protein samples for multiplexed analysis and comparison.
iTRAQ ¼ isobaric tags for relative and absolute quantitation; MS ¼ mass spectrometry; SRM ¼ selected reaction monitoring; TMT ¼ tandem mass tags. 
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For example, although the hypertrophic heart is known to switch in fuel preference from fatty acid to glucose, the expression of glycolytic proteins does not change accordingly (71) . Instead, the turnover of 
